申请人:American Home Products Corporation
公开号:US05221686A1
公开(公告)日:1993-06-22
This invention relates to novel spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides characterized by the general formula (I), ##STR1## wherein R is lower alkyl containing 1 to 6 carbon atoms, cycloalkyl containing 5 to 6 carbon atoms, allyl, benzyl, halogen substituted benzyl, aralkyl containing 7 to 10 carbon atoms, halogen substituted aralkyl containing 7 to 10 carbon atoms; 3-phenyl-2-propynyl and halogen substituted 3-phenyl-2-propynyl and the pharmaceutically acceptable salts thereof, to the processes for their preparation, to methods for using the compounds, and to pharmaceutical compositions thereof. The compounds have pharmaceutical properties which render them beneficial for the treatment of diabetes mellitus and associated diabetic complications.
这项发明涉及一种新型的螺[1,2-苯并异噻唑-3(2H),5'-噁唑啉]-2',4'-二酮1,1-二氧化物,其一般式为(I),其中R是含有1至6个碳原子的低碳链烷基,含有5至6个碳原子的环烷基,烯丙基,苄基,卤素取代苄基,含有7至10个碳原子的芳基烷基,卤素取代的含有7至10个碳原子的芳基烷基;3-苯基-2-丙炔基和卤素取代的3-苯基-2-丙炔基及其药学上可接受的盐,以及它们的制备方法,使用这些化合物的方法,以及它们的药物组成物。这些化合物具有药理特性,使它们对糖尿病及相关并发症的治疗有益。